Cushing syndrome, Europe, article, bronchus carcinoid, bronchus tumor, cancer classification, cancer staging, carcinoid, chromogranin A, cisplatin, clinical trial, cyclophosphamide, doxorubicin, etoposide, fluorouracil, follow up, human, large cell carcinoma, lung small cell cancer, lung tumor, neuroendocrine tumor, practice guideline, priority journal, prognosis, risk assessment, somatostatin derivative, somatostatin receptor, survival rate, temozolomide, thymoma, treatment response, tumor recurrence, tumor regression, vincristine
dx.doi.org/10.1093/annonc/mdq191, hdl.handle.net/1765/20747
Annals of Oncology
Free full text at PubMed
Erasmus MC: University Medical Center Rotterdam

Öberg, K, Hellman, P, Kwekkeboom, D, & Jelic, S. (2010). Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 21(SUPPL. 5). doi:10.1093/annonc/mdq191